Published: 23 March 2022
Committees
SUMMARY OF RECOMMENDATIONS FROM THE 115TH MEETING OF THE MEDICINES ASSESSMENT ADVISORY COMMITTEE HELD IN WELLINGTON ON TUESDAY 24 February 2022
4. |
Applications for consent to distribute a new medicine under section 23 of the Medicines Act 1981 (referred by the Minister of Health under section 22(2)) |
4.1 |
Paxlovid (nirmatrelvir), film coated tablet, 150mg/100mg (Pfizer New Zealand Ltd) |
|
|
The Committee recommended that the delegate of the Minister of Health should grant provisional consent to the distribution of this medicine under Section 23 of the Medicines Act 1981 with the conditions proposed by Medsafe. The Committee agreed to Medsafe’s proposal that the provisional consent should have an effect of two years. |
